Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies
Recruiting
N/A
Interventional Study
Artificial Intelligence
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 45 – 89
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 1,596 (estimated)
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM) · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a pragmatic, double-blind, randomized, controlled trial, to evaluate the effect of implementing a Computer-assisted detection (CADe) system within the routine clinical practice of Canadian healthcare institutions.
The main hypothesis of this study is that the ADR in the operating room equipped with the GI genius CADe system will be significantly higher than the ADR in the ordinary operati…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* indication of undergoing a screening, surveillance, or diagnostic colonoscopy
* Age 45-89 years
Exclusion Criteria:
* Patients undergoing emergency colonoscopy
* Patients with a known familial polyposis syndrome or a known inflammatory bowel disease
Contacts
No contact information available.